Aptamer Group PLC (AIM:APTA)

Market Cap	11.23M -57.9%
Revenue (ttm)	1.54M +28.3%
Net Income	-1.86M
EPS	-0.00
Shares Out	3.46B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,364,216
Open	0.3275
Previous Close	0.3250
Day's Range	0.3078 - 0.3500
52-Week Range	0.3000 - 1.1500
Beta	0.85
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 13, 2026

About Aptamer Group

Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and analytical, bioprocessing, diagnostic, cosmetic and consumer health, and therapeutic applications. The company serves pharmaceutical, diagnostic, and b...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 30
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: APTA

Financial Performance

In fiscal year 2026, Aptamer Group's revenue was 1.54 million, an increase of 28.35% compared to the previous year's 1.20 million. Losses were -1.86 million, -23.18% less than in 2025.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 15, 2026

Data Sources Report a data error